UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

Date of Report: May 7, 2015

(Date of earliest event reported)

 

 

TENET HEALTHCARE CORPORATION

(Exact name of Registrant as specified in its charter)

 

 

 

Nevada    1-7293    95-2557091
(State of Incorporation)   

(Commission

File Number)

  

(IRS Employer

Identification Number)

1445 Ross Avenue, Suite 1400

Dallas, Texas 75202

(Address of principal executive offices, including zip code)

(469) 893-2200

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) The 2015 annual meeting of shareholders of Tenet Healthcare Corporation was held on May 7, 2015.

(b) The shareholders (1) elected all of the board’s nominees for director, (2) approved an advisory resolution on the compensation paid to the company’s named executive officers and (3) ratified the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2015.

The final results of voting on each of the matters submitted to a vote are as follows:

1. Election of directors:

 

     FOR      AGAINST      ABSTAIN      BROKER
NON-VOTES
 

Trevor Fetter

     75,787,518         1,494,889         786,675         6,917,427   

Brenda J. Gaines

     74,543,650         2,763,724         761,708         6,917,427   

Karen M. Garrison

     75,657,339         1,651,479         760,264         6,917,427   

Edward A. Kangas

     69,826,997         7,480,615         761,470         6,917,427   

J. Robert Kerrey

     74,435,276         2,873,034         760,772         6,917,427   

Freda C. Lewis-Hall

     75,825,251         1,483,345         760,486         6,917,427   

Richard R. Pettingill

     74,463,192         2,843,450         762,440         6,917,427   

Ronald A. Rittenmeyer

     74,711,219         2,594,959         762,904         6,917,427   

Tammy Romo

     75,822,504         1,484,589         761,989         6,917,427   

James A. Unruh

     75,634,137         1,674,870         760,075         6,917,427   

2. Approval of an advisory resolution on the compensation paid to the company’s named executive officers:

 

FOR   AGAINST   ABSTAIN   BROKER
NON-VOTES
63,683,262   13,558,385   827,435   6,917,427

3. Ratification of the selection of Deloitte & Touche LLP as the company’s independent registered public accountants for the year ending December 31, 2015:

 

FOR   AGAINST   ABSTAIN   BROKER
NON-VOTES
83,180,488   887,038   918,983   —  

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TENET HEALTHCARE CORPORATION
By:

/s/ Paul A. Castanon

Paul A. Castanon
Vice President, Deputy General Counsel and Corporate Secretary

Date: May 8, 2015